
Whitepapers
JCA Readiness: The 3Cs Giving Orphan Drug & ATMP Developers a Competitive Edge
Executive Summary The introduction of the European Joint Clinical Assessment (JCA), a centralized EU process for the scientific analysis of clinical evidence on the relative